Access to anti-retroviral drugs, female in IDA blend
IDA blend: Access to anti-retroviral drugs, female was 88.4% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in IDA blend, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
IDA blend recorded 88.4% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.2% on the previous year and up 79.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in IDA blend peaked at 88.4% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in IDA blend, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.3% | — |
| 2003 | 0.3% | +3.9% |
| 2004 | 1.6% | +446.9% |
| 2005 | 3.3% | +97.5% |
| 2006 | 6.2% | +91.0% |
| 2007 | 8.8% | +41.9% |
| 2008 | 13.3% | +50.3% |
| 2009 | 18.1% | +36.8% |
| 2010 | 24.7% | +36.3% |
| 2011 | 31.9% | +28.8% |
| 2012 | 38.3% | +20.4% |
| 2013 | 42.4% | +10.6% |
| 2014 | 49.3% | +16.4% |
| 2015 | 55.4% | +12.2% |
| 2016 | 62.9% | +13.6% |
| 2017 | 68.8% | +9.4% |
| 2018 | 69.9% | +1.5% |
| 2019 | 72.8% | +4.2% |
| 2020 | 76.0% | +4.4% |
| 2021 | 80.1% | +5.4% |
| 2022 | 83.7% | +4.5% |
| 2023 | 86.5% | +3.4% |
| 2024 | 88.4% | +2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.2% | 0.0% | 18.1% | 10 |
| 2010s | 51.6% | 24.7% | 72.8% | 10 |
| 2020s | 83.0% | 76.0% | 88.4% | 5 |
Countries ranked near IDA blend
More gender data for IDA blend
- Labor force, female 110.95 million (2025)
- Labor force, female, per capita 0.1609 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.73 % change on previous year (2025)
- Labor force, female, per square kilometre 21.38 units per square kilometre (2023)
- Ratio of female to male youth unemployment rate (% ages 15-24) 130.6% (2025)
- School life expectancy, primary to tertiary, female 8.56 years (2019)
- School life expectancy, primary to tertiary, male 9.46 years (2019)
- Proportion of women in ministerial level positions 16.4% (2025)
- Literacy rate, adult female 61.5% (2024)
Frequently asked questions
- What is access to anti-retroviral drugs, female in IDA blend?
- Access to anti-retroviral drugs, female in IDA blend was 88.4% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in IDA blend?
- The highest recorded value was 88.4% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in IDA blend?
- The lowest recorded value was 0.0% in 2000.
- How does IDA blend rank for access to anti-retroviral drugs, female?
- IDA blend ranks 3rd out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in IDA blend?
- Over the last ten years it is up 79.2%. The long-run trend across the full record is volatile.
- Where does this IDA blend data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.